Health Observance

Debunking common myths about arthritis

May is Arthritis Awareness Month
Racheal D'Souza
May 3, 2022

Arthritis causes pain, swelling and inflammation of one or multiple joints. It’s not a single disease but an umbrella term used to refer to a wide array of conditions. It’s one of the most widespread health conditions in the nation.

There are more than 100 types of arthritis, of which osteoarthritis is the most common. Osteoarthritis, also known as degenerative joint disease, occurs over time due to wear and tear of cartilage that protects the ends of the bones. Although osteoarthritis can damage any joint, the disorder most commonly affects joints in the hands, knees, hips and spine.

There are also inflammatory forms, such as rheumatoid arthritis; psoriatic arthritis; and the arthritis associated with ankylosing spondylitis, lupus and gout. In those cases, inflammation is caused by an overactive immune system that attacks connective tissues. (Learn more about autoinflammatory arthritis.)

In the United States, an estimated 58.5 million individuals are gripped with arthritis — the leading cause of disability. More than 50% of this population fall in the working age group (18 to 64 years).

Despite how common this condition is, there are several myths that persist, making it confusing for patients seeking to relieve their symptoms and to improve their quality of life. This article aims at debunking these long-held myths and getting your facts straight!

Myth #1: Arthritis is an old-age disease and cannot affect children.

Fact: Arthritis is more common in older adults, but there are several types that can affect both children and young adults.

Juvenile idiopathic arthritis (also known as childhood arthritis or juvenile rheumatoid arthritis) is the most common type of arthritis among children and can cause permanent physical damage to joints. According to  Cleveland Clinic, one in 1,000 children (or about 300,000 children in the U.S.) are affected.

Myth #2: All joint pain is arthritis.

Fact: There are many conditions — such as tendonitisbursitis and other soft-tissue injuries — that cause joint pain and have a pain profile similar to that of arthritis. Hence, it is of utmost importance to get an accurate medical diagnosis, preferably by a rheumatologist, before treating any kind of joint pain.

Myth #3: When you start experiencing joint pain, you should wait to see if it goes away on its own.

Fact: False! Diagnosing and treating arthritis at its early stage not only can save your joints but also save you from damage to vital organs. Certain forms, such as rheumatoid arthritis, can damage skin, eyes, lungs, blood vessels, the brain and the heart. It is important to determine which type of arthritis you have right away, because treatment varies and starting the correct treatment can be the key to preventing permanent damage.

Myth #4: Arthritis symptoms cannot be improved.

Fact: There currently isn’t a cure for arthritis. However, treatment focuses on relieving symptoms and improving joint function. Working with an arthritis expert can help.

Depending upon the type of arthritis, certain medications can reduce pain and inflammation. Osteoarthritis often is treated with pain-reducing medications, physical activity, weight loss (if the person is overweight) and self-management education.(Learn more about treatment.) Inflammatory disorders are treated with disease-modifying antirheumatic drugs that suppress the immune system.

Heat and cold treatment and assistive devices, such as walkers, braces and gloves, also can help.

Myth #5: Exercising will worsen your condition.

Fact: Exercise can help increase strength, motion and flexibility and reduce pain and swelling. Inactivity can cause the symptoms to worsen, thus increasing both pain and swelling. Before you enroll in any exercise program, it is also important to know what your limits are and what level of exercise you can benefit from.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Racheal D'Souza

Racheal D’Souza is an associate scientist working on CRISPR, with a strong interest in writing. 
 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Uncovering the molecular roots of fatty liver disease
Interview

Uncovering the molecular roots of fatty liver disease

June 3, 2026

Physician–scientist Silvia Sookoian discusses her path from hepatitis C care to MASLD research, her use of multi-omics to study steatotic liver disease, and how lipid metabolism and genetics are reshaping understanding of MASH and liver health.

Mitochondria shape kidney cell function
Journal News

Mitochondria shape kidney cell function

May 28, 2026

Researchers at the University of Washington, Seattle present the first quantitative comparison of mitochondrial interactomes between two epithelial cell types in the kidney.

Long-chain polyunsaturated fatty acids linked to postoperative delirium risk
Journal News

Long-chain polyunsaturated fatty acids linked to postoperative delirium risk

May 27, 2026

Researchers show that altered lipid metabolism may contribute to postoperative delirium, a condition linked to increased risk for long-term cognitive decline. The study explores potential disease mechanisms, which have yet to be understood.

Glycosylation patterns across antibody isotypes distinguish tuberculosis states
Journal News

Glycosylation patterns across antibody isotypes distinguish tuberculosis states

May 26, 2026

Researchers at Taipei Medical University present the first site-specific glycosylation analysis of immunoglobulins in elderly tuberculosis patients.

Blood glycome possibly predicts lifespan
Journal News

Blood glycome possibly predicts lifespan

May 21, 2026

Researchers at the University of Santiago de Compostela show that total serum N-glycome can predict mortality independent of traditional risk factors.

Building a better model for drug delivery across the blood–brain barrier
Journal News

Building a better model for drug delivery across the blood–brain barrier

May 19, 2026

Industry and academic scientists collaborated to develop a rat with humanized iron-transport receptors, enabling research into iron homeostasis and drugs that cross the brain’s barrier.